Inicio>>5'-N-Ethylcarboxamidoadenosine (hydrate)

5'-N-Ethylcarboxamidoadenosine (hydrate) (Synonyms: Adenosine 5'-ethylcarboxamide, NECA)

Catalog No.GC46708

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

5'-N-Ethylcarboxamidoadenosine (hydrate) Chemical Structure

Cas No.: N/A

Tamaño Precio Disponibilidad Cantidad
5 mg
43,00 $
Disponible
10 mg
77,00 $
Disponible
25 mg
150,00 $
Disponible
50 mg
253,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

5'-N-Ethylcarboxamidoadenosine (NECA) is an adenosine analog that acts as an agonist of adenosine receptors (Kis = 1,880, 6,660, and 3.5 nM for human adenosine subtypes A1, A2A, and A3, respectively).1 NECA is reported to act as a potent vasodilator and can inhibit platelet aggregation by increasing cAMP (EC50 = 3.1 µM).2,3

1.Volpini, R., Dal ben, D., Lambertucci, C., et al.N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptorJ. Med. Chem.50(6)1222-1230(2007) 2.de Zwart, M., Link, R., von Frijtag Drabbe KÜnzel, J.K., et al.A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonistsNucleosides Nucleotides17(6)969-985(1998) 3.Cusack, N.J., and Hourani, S.M.O.5'-N-ethylcarboxamidoadenosine: A potent inhibitor of human platelet aggregationBr. J. Pharmacol.72(3)443-447(1981)

Reseñas

Review for 5'-N-Ethylcarboxamidoadenosine (hydrate)

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5'-N-Ethylcarboxamidoadenosine (hydrate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.